Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019

Figure 1

Flow diagram to show patient inclusion and exclusion criteria. 610 patients were found with VT and 463 were included in our analysis: 199 received VKAs, 77 received NOACs, and 187 received antiplatelet therapy. A total of 212 patients had the follow-up image: 53 in NOACs, 92 in VKAs, and 67 in antiplatelet therapy. VT: ventricular thrombus; N: number of patients; NOACs: non-vitamin K antagonist oral anticoagulants; VKAs: vitamin K antagonists.